Liquid biopsy approaches to capture minimal residual disease and therapy response in patients with early stage cancers
{{output}}
Liquid biopsies are emerging as promising approaches to capture minimal residual disease (MRD) and interpret the heterogeneity of pathological responses after neoadjuvant therapy for patients with early stage cancers. Minimally invasive analyses of circulating... ...
